Setastine Hydrochloride

盐酸司他斯汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSetastine Hydrochloride
Drug Alias Name司他斯汀setastinumsetastinaLoderixEGYT-2062 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityUrticariaRhinitis, Allergic, Perennial
Global Approved IndicationsHypersensitivityUrticariaRhinitis, Allergic, Perennial
Approved Indications in ChinaHypersensitivityUrticariaRhinitis, Allergic, Perennial
Original Approved Country/TerritoryHungary
Original Approved Date1987/01/01
Country/TerritoryHungaryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEgis Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesEgis Group IncHuiyinbi Group Fuzhou Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivityUrticariaRhinitis, Allergic, Perennial
Inactive IndicationsN/A

Other Information

ATC CodeD11AHR06A
Related LinksWikipedia